Cited by 53Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesDementia and Cognitive Impairment Research

Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients

Open access
Savaskan, Egemen, Müller, Sandra E., Böhringer, Andreas, Schulz, André, Schächinger, Hartmut·2008·The International Journal of Neuropsychopharmacology

Abstract

Depression is a common disorder in the elderly handicapping patients with affective and cognitive symptoms. Because of their good tolerability relative to the older tricyclic compounds, selective serotonin reuptake inhibitors (SSRIs) are increasingly used for the treatment of depression in the elderly. Little is known about their effects on cognition in elderly patients. In the present 4-wk, single-centre, randomized, open-label trial we investigated the antidepressive effects of escitalopram, an SSRI, in 18 elderly depressed patients [mean age (+/-s.e.m.) 76.2+/-1.8 yr] compared to 22 healthy age-matched controls (mean age 76.9+/-1.8 yr). Affective and cognitive symptoms were assessed using the Geriatric Depression Scale (GDS), Mini-Mental State Examination (MMSE), and a face portrait recognition test to assess memory for happy and angry faces. Depressed patients prior to treatment had markedly reduced memory performance. Treatment with escitalopram improved affective and cognitive symptoms significantly. Furthermore, escitalopram treatment improved memory for negative facial stimuli. Control subjects confirmed the well- established memory bias favouring recognition of identities acquired with happy expressions. Importantly, this bias was absent in depressed patients prior to, but also after treatment. In conclusion, escitalopram, even after a relatively short treatment period, was effective in treating depression in the elderly and may help improve cognitive performance for social stimuli.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145707007997

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [1]1. Beck AT, Rush AJ, Shaw BF, Emery G (1979). Cognitive Therapy of Depression. New York : Guilford Press.
  2. [6]6. Coyne JC, Burchill SAL, Stiles WB (1991). An interactional perspective on depression. In : Snyder CR, Forsyth DO (Eds.). Handbook of Social and Clinical Psychology (pp. 327-349). New York : Pergamon.
  3. [12]12. Gotlib IH, Hammen CL (1992). Psychological Aspects of Depression : Toward a Cognitive-Interpersonal Integration. Chichester : John Wiley.

Cited by

Sorted by citations

Authors
Savaskan, E., Müller, S. E., Böhringer, A., Schulz, A., & Schächinger, H.
Affiliations
  • Universitäre Psychiatrische Kliniken Basel (CH)
  • Universität Trier (DE)
Corresponding author
Savaskan, Egemen
Venue
The International Journal of Neuropsychopharmacology
Published
2007-08-13
Volume
11
Issue
03
Pages
381-8
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2141083150
Cited by
53
References
42
Citations by year
2026: 2 · 2025: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 7 · 2014: 6 · 2012: 6
FWCI
3.10
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
escitalopram, geriatric depression, selective serotonin reuptake inhibitors, cognitive symptoms, mood, Geriatric Depression Scale, Mini-Mental State Examination, antidepressant effects
MeSH terms
Affect, Aged, Antidepressive Agents, Cognition, Depression, Emotions, Female, Geriatrics, Humans, Male, Memory, Mental Status Schedule, Neuropsychological Tests, Pattern Recognition, Visual, Photic Stimulation, Citalopram

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review